Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:59 PM
Ignite Modification Date:
2025-12-24 @ 3:59 PM
NCT ID:
NCT03505892
Eligibility Criteria:
Inclusion Criteria:
* Participants with confirmed AS.
* Participant will start adalimumab as treatment
* Participant must provide the written authorization form and agree to provide personal and/or health data prior to the entry into the study.
Exclusion Criteria:
* Participant has been treated with any investigational drug or biologic within a minimum of 30 days or five half-lives (whichever is longer) of the drug prior to the Baseline Visit.
* Participants who fulfill any of the contraindications as per Humira label in Taiwan.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03505892
Study Brief:
Protocol Section:
NCT03505892